ITI is a program of The Task Force for Global Health.
Mozambique conducted population-based trachoma prevalence surveys in 2011 followed by the Global Trachoma Mapping Project (GTMP) supported prevalence surveys in 2013 and 2014. While the initial round of surveys indicated high endemicity, subsequent surveys using the GTMP platform indicated lower prevalence. Full SAFE implementation began in the Niassa province in 2013, followed by impact surveys in 2015 and SAFE implementation in the remaining provinces in 2014 and 2015. A trachoma action plan workshop was conducted in 2014 and a regional TAP workshop was conducted in Nampula province in April 2016.
Partners in full SAFE implementation include the ENVISION project led by RTI International, Sightsavers, and the Queen Elizabeth Diamond Jubilee Trust.
CURRENT IMPLEMENTATION STATUS
A total of 39 districts in the provinces of Cabo Delgado, Manica, Nampula, Sofala, Tete, and Zambezia are scheduled to conduct MDAs in 2017. Impact surveys will be conducted in five districts in Cabo Delgado; four districts in Tete, and two districts in Nampula in May 2017. Surveillance surveys will be conducted in the Niassa province districts in July 2017.
In February 2017, ITI was led to understand that the donated Zithromax® was used for purposes other than what was stipulated in the MOU between ITI and the MOH. The national program worked with ITI and RTI on a program and supply chain assessment for an in-depth understanding of the problem.
Future shipments are contingent on corrective actions that will be taken to address the problem.
Zithromax® Shipments by Year